StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
BioNTech SE
Frankfurt Stock Exchange:22UA.F
Sector
Industries
Location
Market Cap
USD 26.19 B
Share Price
USD 108.96
Avg Daily Volume
2,220
Change (1 day)
0.75%
Change (1 year)
37.96%
Change (YTD)
-3.68%
BioNTech SE Free Cash Flow for the year ending December 31, 2024: USD -253.28 M
BioNTech SE Free Cash Flow is USD -253.28 M for the year ending December 31, 2024, a -104.92% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
BioNTech SE Free Cash Flow for the year ending December 31, 2023 was USD 5.15 B, a -63.57% change year over year.
-
BioNTech SE Free Cash Flow for the year ending December 31, 2022 was USD 14.14 B, a 1,588.19% change year over year.
-
BioNTech SE Free Cash Flow for the year ending December 31, 2021 was USD 837.48 M, a -793.07% change year over year.
-
BioNTech SE Free Cash Flow for the year ending December 31, 2020 was USD -120.84 M, a -60.06% change year over year.
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%